title: Trans-Sector Integrated Treatment in Psychosis and Addiction.
abstract: BACKGROUND
  Patients with psychosis often develop comorbid addiction, with a lifetime prevalence of ca. 50%. Dual diagnoses are considered hard to treat. Long-term integrated treatment programs might improve such patients' outcomes, at least to a moderate extent, but they have not yet been adequately studied or implemented in Germany to date.
  
  
  METHODS
  100 dual diagnosis patients participated in a single-center, randomized, controlled trial under standard hospital treatment conditions. They were randomly allotted to two groups. Patients in the intervention group were admitted to a specialized open hospital ward, where they were given integrated treatment, including disorder-specific group therapy. Their treatment was continued with further disorder-specific group therapy in the outpatient setting. Patients in the control group were admitted to an open general psychiatric ward and received treatment as usual, but no disorder-specific treatment either during their hospitalization or in the subsequent outpatient phase. Follow-up examinations were performed three, six, and twelve months after inclusion. The primary outcome was defined as the changes in substance use and abstinence motivation. The secondary outcome consisted of the patients' satisfaction with treatment and with life in general, retention rate, psychopathology, rehospitalizations, and global level of functioning.
  
  
  RESULTS
  The patients in the intervention group developed higher abstinence motivation than those in the control group (p = 0.009) and transiently reduced their substance use to a greater extent (p = 0.039 at three months). They were also more satisfied with their treatment (group effect: p = 0.011). Their global level of functioning and their retention rate were also higher, but these differences did not reach statistical significance.
  
  
  CONCLUSIONS
  Low-threshold, motivational, integrated treatment programs with psycho-educative and behavioral therapeutic elements may be helpful in the treatment of dual diagnosis patients and should be more extensively implemented as part of standard hospital treatment. Larger-scale, methodologically more complex studies will be needed to identify subgroups of patients that respond to such treatments in different ways.
authors.affiliation: LVR-Klinik Köln:, Department of Psychiatry and Psychotherapy, University of Cologne.
authors.forename: Euphrosyne
authors.initials: E
authors.lastname: Gouzoulis-Mayfrank
authors.forename: Susanne
authors.initials: S
authors.lastname: König
authors.forename: Stefan
authors.initials: S
authors.lastname: Koebke
authors.forename: Thomas
authors.initials: T
authors.lastname: Schnell
authors.forename: Mario
authors.initials: M
authors.lastname: Schmitz-Buhl
authors.forename: Jörg
authors.initials: J
authors.lastname: Daumann
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents; D001521:Behavior Therapy / Q000379:methods; D003131:Combined Modality Therapy / Q000379:methods; D019033:Delivery of Health Care, Integrated / Q000706:statistics & numerical data*; D017831:Diagnosis, Dual (Psychiatry); D005081:Exercise Therapy / Q000379:methods; D005260:Female; D005858:Germany; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D017060:Patient Satisfaction; D011615:Psychotherapy, Group / Q000379:methods; D011618:Psychotic Disorders / Q000175:diagnosis / Q000523:psychology / Q000628:therapy*; D019966:Substance-Related Disorders / Q000175:diagnosis / Q000523:psychology / Q000628:therapy*; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents